Substance P potentiates TGF-β1 production in lung epithelial cell lines

Iranian Journal of Allergy, Asthma and Immunology

Volumn 8, Issue 1, 2009, Pages 19-24

  Yaraee, Roya ^a   Ghazanfari, Tooba ^a  

^a SHAHED UNIVERSITY   (Iran)

Author keywords

Bronchoepithelial cell line; CP 96345; Substance P; Transforming growth factor beta (TGF )

Indexed keywords

2 BENZHYDRYL 3 (2 METHOXYBENZYLAMINO) 1 AZABICYCLO[2.2.2]OCTANE; SUBSTANCE P; TRANSFORMING GROWTH FACTOR BETA1; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; BIPHENYL DERIVATIVE;

ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; CELL REGENERATION; CELL VIABILITY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; IMMUNOMODULATION; LUNG ALVEOLUS EPITHELIUM; LUNG FIBROSIS; LUNG FUNCTION; REGULATORY MECHANISM; BIOSYNTHESIS; CELL LINE; CELL SURVIVAL; CYTOLOGY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; EPITHELIUM CELL; LUNG; METABOLISM; TUMOR CELL LINE;

BIPHENYL COMPOUNDS; CELL LINE; CELL LINE, TUMOR; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EPITHELIAL CELLS; HUMANS; LUNG; NEUROTRANSMITTER AGENTS; SUBSTANCE P; TRANSFORMING GROWTH FACTOR BETA1;

EID: 69249214189     PISSN: 17351502     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Coker RK, Laurent GJ. Pulmonary fibrosis: cytokines in the balance. Eur Respir J 1998; 11:1218-21.
2. Toews GB. Cytokines and the lung. Eur Respir J 2001; 18(Suppl)34:3s-17s.
3. Kwong, KY, Literat A, Zhu NL, Huang HH, Li C, Jones CA, et al. Expression of transforming growth factor beta (TGF-β1) in human epithelial alveolar cells: a pro-inflammatory mediator independent pathway. Life Sci 2004; 74(24):2941-57.
4. Joos GF, De Swert KO, Pauwels RA. Airway inflammation and tachykinins: prospects for the development of tachykinin receptor antagonists. Eur J Pharmacol 2001; 429(1-3):239-50.
5. Germonpre PR, Bullock GR, Lambrecht BN, Van de Velde V, Luyten WH Joos GF, Pauwels RA. Presence of substance P and neurokinin 1 receptors in human sputum macrophages and U-937 cells. Eur Respir J 1999; 14(4):776-82.
6. Springera J, Groneberga DA, Preglac R, Fischera A. Inflammatory cells as source of tachykinin-induced mucus secretion in chronic bronchitis. Regul Peptides 2005; 124(1-3):195-201.
7. Killingsworth CR, Paulauskis JD, Shore SA. Substance P content and preprotachykinin Gene-1 mRNA expression in a rat model of chronic bronchitis. Am J Respir Cell Mol Biol 1996; 14(14):334-40.
8. Springer J, Fischer A. Substance P-induced pulmonary vascular remodelling in precision cut lung slices. Eur Respir J 2003; 22(4):596-601.
9. Veronesi B, Carter JD, Devlin RB, Simon SA., Oortgiesen M. Neuropeptides and capsaicin stimulate the release of inflammatory cytokines in a human bronchial epithelial cell line. Neuropeptides 1999; 33(6):447-56.
10. Yaraee R, Ebtekar M, Ahmadiani A, Sabahi F. Neuropeptides (SP and CGRP) augment proinflammatory cytokine production in HSV-infected macrophages. Int Immunopharmacol 2003; 3(13-14):1883-7.
11. Leask A, Abraham DJ. TGF-b signaling and the fibrotic response. FASEB J 2004; 18(17):816-27.
12. Schmidt-Weber CB, Blaser K. Regulation and role of transforming growth factor-b in immune tolerance induction and inflammation. Curr Opin Immunol 2004; 16:709-16.
13. Blobe GC, Schiemann WP, Lodish HF. Role of transforming growth factor beta in human disease. N Engl J Med 2000; 342(18):1350-8.
14. Aghanouri R, Ghanei M, Aslani J, Keivani-Amine H, Rastegar F, Karkhane A. Fibrogenic cytokine levels in bronchoalveolar lavage aspirates 15 years after exposure to sulfur mustard. Am J Physiol Lung Cell Mol Physiol 2004; 287(6):L1160-4.
15. Xu YD, Hua J, Mui A, O'Connor R, Grotendorst G, Khalil N. Release of biologically active TGF-beta1 by alveolar epithelial cells results in pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 2003; 285(3):L527-39.
16. Bergeron A, Soler P, Kambouchner M, Loiseau P, Milleron B, Valeyre D, et al. Cytokine profiles in idiopathic pulmonary fibrosis suggest an important role for TGF-b and IL-10. Eur Respir J 2003; 22(1):69-76.
17. Takeyama M, Nagai S, Mori K, Ikawa K, Satake N, Izumi T. Substance P-like immunoreactive substance in bronchoalveolar lavage fluids from patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 1996; 13(1):33-7.
18. Williams R, Zou X, Hoyle GW. Tachykinin-1 receptor stimulates proinflammatory gene expression in lung epithelial cells through activation of NF-kB via a Gq-dependent pathway. Am J Physiol Lung Cell Mol Physiol 2007; 292(2):L430-7.
19. Katayama I, Nishioka K. Substance P augments fibrogenic cytokine-induced fibroblast proliferation: possible involvement of neuropeptide in tissue fibrosis. J Dermatol Sci 1997; 15(3):201-6.
20. Rameshwar P, Oh HS, Yook C, Gascon P, Chang VT. Substance p-fibronectin-cytokine interactions in myeloproliferative disorders with bone marrow fibrosis. Acta. Haematol 2003; 109(1):1-10.
21. Williams T J, Wilson JW. Challenges in pulmonary fibrosis: 7 Novel therapies and lung transplantation. Thorax 2008; 63(3):277-84.
22. Hu D, Chen B, Zhu X, Tao K, Tang C, Wang J. Substance P up-regulates the TGF-beta 1 mRNA expression of human dermal fibroblasts in vitro. Zhonghua Zheng Xing Wai Ke Za Zhi 2002; 18(4):234-6.
23. Marriott I, Bost KL. Substance P diminishes lipopolysaccharide and interferon-γ-induced TGF-β1 production by cultured murine macrophages. Cell Immunol 1998; 183(2):113-20.